Qizhizhi data shows that China-US Crown Biotechnology (Taicang) Co., Ltd. was established on November 7, 2008, with a registered capital of US$22 million and 410 insured persons. It is a pharmaceutical manufacturing company. Mainly a national high-tech enterprise. The company has been awarded qualifications and honors such as "National High-tech Enterprise" and "Innovative Small and Medium-sized Enterprises".
In terms of intellectual property rights, Sino-US Crown Biotechnology (Taicang) Co., Ltd. has 4 registered trademarks, 10 software copyrights, and 29 patent information. In addition, Sino-US Crown Biotechnology (Taicang) Co., Ltd. has invested in 3 companies and directly controls 1 company.